IMUNON INC (IMNN)

US15117N6022 - Common Stock

0.83  -0.02 (-2.83%)

After market: 0.83 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
500K500K500K
-100.00%
7.48M34.102M
355.91%
105.66M
209.84%
226.39M
114.26%
710.84M
213.99%
EBITDA
YoY % growth
-17.75M
10.58%
-20.31M
-14.42%
-24.19M
-19.10%
N/A
14.09%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-18.49M
10.11%
-21.01M
-13.63%
-24.92M
-18.61%
-19.686M
15.61%
-21.284M
-1.20%
-29.912M
-40.54%
-37.205M
-24.38%
-50.711M
-36.30%
-44.829M
11.60%
13.458M
130.02%
150.55M
1,018.67%
562.28M
273.48%
Operating Margin
-3,698.00%-4,202.00%-4,984.00%N/AN/AN/AN/A-677.95%-131.46%12.74%66.50%79.10%
EPS
YoY % growth
-10.05
9.46%
N/A
58.90%
-5.17
-25.15%
-2.11
57.83%
-1.73
20.81%
-1.13
34.42%
-0.91
19.37%
-1.02
-11.73%
-0.31
70.00%
0.66
316.67%
2.47
272.31%
7.57
206.61%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.37
28.89%
-0.39
25.46%
-0.39
24.00%
-0.38
-11.00%
-0.37
0.69%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.991M
-0.39%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.34
8.11%
-0.410.0716.14%
Q2 2024
Q2Q % growth
-0.51
16.39%
-0.550.047.97%
Q1 2024
Q2Q % growth
-0.52
23.53%
-0.580.0610.04%
Q4 2023
Q2Q % growth
-0.52
67.70%
-0.42-0.10-24.34%
Q3 2023
Q2Q % growth
-0.37
57.47%
-0.670.3045.04%
Q2 2023
Q2Q % growth
-0.61
29.89%
-0.720.1115.17%
Q1 2023
Q2Q % growth
-0.68
62.64%
-0.680.00-0.50%
Q4 2022
Q2Q % growth
-1.61
55.52%
-0.87-0.74-85.70%
Q3 2022
Q2Q % growth
-0.87
3.33%
-0.83-0.04-5.30%
Q2 2022
Q2Q % growth
-0.87
3.33%
-1.140.2724.01%
Q1 2022
Q2Q % growth
-1.82 -1.01-0.81-80.23%
Q4 2021
Q2Q % growth
-3.62
-382.67%
-0.92-2.70-294.34%
Q3 2021
Q2Q % growth
-0.90
75.00%
-1.220.3226.47%
Q2 2021
Q2Q % growth
-0.90
66.67%
-1.220.3226.47%
Q4 2020
Q2Q % growth
-0.75
50.00%
-1.991.2462.29%
Q3 2020
Q2Q % growth
-3.60
4.00%
-1.94-1.66-85.75%
Q2 2020
Q2Q % growth
-2.70
37.93%
-2.14-0.56-26.05%
Q1 2020
Q2Q % growth
-3.00
-100.00%
-2.60-0.40-15.34%
Q4 2019
Q2Q % growth
-1.50
64.29%
-3.011.5150.15%
Q3 2019
Q2Q % growth
-3.75
3.85%
-4.330.5813.49%
Q2 2019
Q2Q % growth
-4.35
36.96%
-4.850.5010.22%
Q1 2019
Q2Q % growth
-1.50 -4.132.6363.69%
Q4 2018
Q2Q % growth
-4.20 -2.09-2.11-100.86%
Q3 2018
Q2Q % growth
-3.90 -3.37-0.53-15.86%
Q2 2018
Q2Q % growth
-6.90 -4.13-2.77-67.03%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth

-100.00%
%
Q3 2023
Q2Q % growth

-100.00%
%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth
130K 119.003K10.997K9.24%
Q3 2022
Q2Q % growth
130K 110.497K19.503K17.65%
Q2 2022
Q2Q % growth
130K 82.875K47.125K56.86%
Q1 2022
Q2Q % growth
130K 102K28K27.45%
Q4 2021
Q2Q % growth
130K 127.5K2.5K1.96%
Q3 2021
Q2Q % growth
130K 114.75K15.25K13.29%
Q2 2021
Q2Q % growth
130K %
Q1 2021
Q2Q % growth
130K %
Q4 2020
Q2Q % growth
130K 127.5K2.5K1.96%
Q3 2020
Q2Q % growth
130K 86.7K43.3K49.94%
Q2 2020
Q2Q % growth
130K 86.7K43.3K49.94%
Q1 2020
Q2Q % growth
130K 130.05K-50-0.04%
Q4 2019
Q2Q % growth
130K 86.7K43.3K49.94%
Q3 2019
Q2Q % growth
130K 86.7K43.3K49.94%
Q2 2019
Q2Q % growth
130K 129.203K796.59999999999130.62%
Q1 2019
Q2Q % growth
130K 130.05K-50-0.04%
Q4 2018
Q2Q % growth
130K 129.203K796.59999999999130.62%
Q3 2018
Q2Q % growth
130K 132.6K-2.6K-1.96%
Q2 2018
Q2Q % growth
130K 132.6K-2.6K-1.96%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 4.51% 0.25%
RevenueN/A N/A N/A N/A